2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology

Cardiovasc Pathol. Jul-Aug 2012;21(4):245-74. doi: 10.1016/j.carpath.2011.10.001. Epub 2011 Dec 3.

Abstract

The Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology have produced this position paper concerning the current role of endomyocardial biopsy (EMB) for the diagnosis of cardiac diseases and its contribution to patient management, focusing on pathological issues, with these aims: • Determining appropriate EMB use in the context of current diagnostic strategies for cardiac diseases and providing recommendations for its rational utilization • Providing standard criteria and guidance for appropriate tissue triage and pathological analysis • Promoting a team approach to EMB use, integrating the competences of pathologists, clinicians, and imagers.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Adult
  • Aged, 80 and over
  • Biopsy*
  • DNA, Viral / analysis
  • Endocardium / pathology*
  • Female
  • Heart Diseases / diagnosis*
  • Heart Diseases / genetics
  • Humans
  • Male
  • Middle Aged
  • Myocardium / pathology*
  • Pathology, Molecular
  • Societies, Medical

Substances

  • DNA, Viral